Low JT, Ostrom QT, Cioffi G et al (2022) Primary brain and other central nervous system tumors in the United States (2014–2018): a summary of the CBTRUS statistical report for clinicians. Neurooncol Pract 9:165–182

PubMed  PubMed Central  Google Scholar 

Miller KD, Ostrom QT, Kruchko C et al (2021) Brain and other central nervous system tumor statistics. CA Cancer J Clin 71:381–406

Article  PubMed  Google Scholar 

Brown TJ, Bota DA, Van Den Bent MJ et al (2019) Management of low-grade glioma: a systematic review and meta-analysis. Neurooncol Pract 6:249–258

PubMed  Google Scholar 

Louis DN, Perry A, Reifenberger G et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820

Article  PubMed  Google Scholar 

Claus EB, Walsh KM, Wiencke JK et al (2015) Survival and low-grade glioma: the emergence of genetic information. Neurosurg Focus 38:E6

Article  PubMed  PubMed Central  Google Scholar 

Weller M, Van Den Bent M, Tonn JC et al (2017) European association for neuro-oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. Lancet Oncol 18:e315–e329

Article  PubMed  Google Scholar 

Yan Z, Wang J, Dong Q et al (2022) Predictors of tumor progression of low-grade glioma in adult patients within 5 years follow-up after surgery. Front Surg 9:937556

Article  PubMed  PubMed Central  Google Scholar 

Duffau H (ed) (2017) Diffuse low-grade gliomas in adults. Springer, Cham https://doi.org/10.1007/978-3-319-55466-2

Book  Google Scholar 

Wang TJC, Mehta MP (2019) Low-grade glioma radiotherapy treatment and trials. Neurosurg Clin N Am 30:111–118

Article  CAS  PubMed  Google Scholar 

Tabrizi S, Yeap BY, Sherman JC et al (2019) Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma. Radiother Oncol 137:95–101

Article  PubMed  PubMed Central  Google Scholar 

Dhawan S, Patil CG, Chen C, Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group et al (2020) Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas. Cochrane Database Syst Rev 1:

Suchonwanit P, McMichael AJ (2018) Alopecia in association with malignancy: a review. Am J Clin Dermatol 19:853–865

Article  PubMed  Google Scholar 

In’T Ven L, Compter I, Van Eijsden K et al (2022) Pre-treatment visualization of predicted radiation-induced acute alopecia in brain tumour patients. Clin Transl Radiat Oncol 33:106–111

PubMed  Google Scholar 

Lawenda BD, Gagne HM, Gierga DP et al (2004) Permanent alopecia after cranial irradiation: dose-response relationship. Int J Radiat Oncol Biol Phys 60:879–887

Article  PubMed  Google Scholar 

Scoccianti S, Simontacchi G, Greto D et al (2020) Dosimetric predictors of acute and chronic alopecia in primary brain cancer patients treated with volumetric modulated arc therapy. Front Oncol 10:467

Article  PubMed  PubMed Central  Google Scholar 

Phillips GS, Freret ME, Friedman DN et al (2020) Assessment and treatment outcomes of persistent radiation-induced alopecia in patients with cancer. JAMA Dermatol 156:963

Article  PubMed  Google Scholar 

Torizuka D, Uto M, Umeda K et al (2023) A scalp dose threshold for preventing permanent alopecia in scalp-avoidance whole-brain irradiation with volumetric modulated arc radiation therapy for pediatric patients with Medulloblastomas. Int J Radiat Oncol Biol Phys 116:889–893

Article  PubMed  Google Scholar 

Sprave T, Verma V, Förster R et al (2018) Radiation-induced acute toxicities after image-guided intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for patients with spinal metastases (IRON-1 trial): First results of a randomized controlled trial. Strahlenther Onkol 194:911–920

Article  PubMed  Google Scholar 

Van Der Veen J, Nuyts S (2017) Can intensity-modulated-radiotherapy reduce toxicity in head and neck squamous cell carcinoma? Cancers 9:135

Article  Google Scholar 

Sveistrup J, Af Rosenschöld PM, Deasy JO et al (2014) Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance. Radiat Oncol 9:44

Article  PubMed  PubMed Central  Google Scholar 

Gondi V, Pugh SL, Tome WA et al (2014) Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol 32:3810–3816

Article  PubMed  PubMed Central  Google Scholar 

Mishra MV, Aggarwal S, Bentzen SM et al (2017) Establishing evidence-based indications for proton therapy: an overview of current clinical trials. Int J Radiat Oncol Biol Phys 97:228–235

Article  PubMed  Google Scholar 

Eekers DBP, Roelofs E, Cubillos-Mesías M et al (2019) Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial. Acta Oncol 58:57–65

Article  CAS  PubMed  Google Scholar 

Thurin E, Nyström PW, Smits A et al (2018) Proton therapy for low-grade gliomas in adults: a systematic review. Clin Neurol Neurosurg 174:233–238

Article  PubMed  Google Scholar 

Langendijk JA, Lambin P, De Ruysscher D et al (2013) Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. Radiother Oncol 107:267–273

Article  CAS  PubMed  Google Scholar 

Eekers DB, ’T Ven IL, Roelofs E et al (2018) The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology. Radiother Oncol 128:37–43

Article  PubMed  Google Scholar 

Takaoka T, Tomita N, Mizuno T et al (2021) Dosimetric comparison of helical tomotherapy and intensity-modulated proton therapy in hippocampus- and scalp-sparing whole brain radiotherapy. Technol Cancer Res Treat 20:153303382110601

Article  Google Scholar 

Lambrecht M, Eekers DBP, Alapetite C et al (2018) Radiation dose constraints for organs at risk in neuro-oncology; the European particle therapy network consensus. Radiother Oncol 128:26–36

Article  PubMed  Google Scholar 

Pidikiti R, Patel BC, Maynard MR et al (2018) Commissioning of the world’s first compact pencil-beam scanning proton therapy system. J Appl Clin Med Phys 19:94–105

Article  PubMed  Google Scholar 

Grégoire V, Mackie TR (2011) State of the art on dose prescription, reporting and recording in intensity-modulated radiation therapy (ICRU report no. 83). Cancer Radiother 15:555–559

Article  PubMed  Google Scholar 

Paus R, Haslam IS, Sharov AA et al (2013) Pathobiology of chemotherapy-induced hair loss. Lancet Oncol 14:e50–e59

Article  CAS  PubMed  Google Scholar 

Niazi MZK, Chen Y, Liu H et al (2022) Efficacy of scalp-sparing VMAT approach in reducing scalp radiation dose for patients with glioblastoma. Int J Radiat Oncol Biol Phys 114:e76–e77

Article  Google Scholar 

Palma G, Taffelli A, Fellin F et al (2020) Modelling the risk of radiation induced alopecia in brain tumor patients treated with scanned proton beams. Radiother Oncol 144:127–134

Article  CAS  PubMed  Google Scholar 

Dutz A, Lühr A, Agolli L et al (2019) Development and validation of NTCP models for acute side-effects resulting from proton beam therapy of brain tumours. Radiother Oncol 130:164–171

Article  PubMed  Google Scholar 

Hansen CR, Crijns W, Hussein M et al (2020) Radiotherapy treatment plannINg study guidelines (RATING): a framework for setting up and reporting on scientific treatment planning studies. Radiother Oncol 153:67–78

Article  PubMed  Google Scholar 

Adeberg S, Harrabi S, Bougatf N et al (2018) Dosimetric comparison of proton radiation therapy, volumetric modulated arc therapy, and three-dimensional conformal radiotherapy based on Intracranial tumor location. Cancers 10:401

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eulitz J, Troost EGC, Raschke F et al (2019) Predicting late magnetic resonance image changes in glioma patients after proton therapy. Acta Oncol 58:1536–1539

Article  CAS  PubMed  Google Scholar 

Wang C‑C, McNamara AL, Shin J et al (2020) End-of-range radiobiological effect on rib fractures in patients receiving proton therapy for breast cancer. Int J Radiat Oncol Biol Phys 107:449–454

Article  PubMed  PubMed Central  Google Scholar 

Harrabi SB, Seidensaal K, Bauer J et al (2022) Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma—how safe are protons? Radiother Oncol 167:211–218

Article  PubMed  Google Scholar 

Sã BS (2021) Does the uncertainty in relative biological effectiveness affect patient treatment in proton therapy? Radiother Oncol 163:177–184

Article  Google Scholar 

Kern A, Bäumer C, Kröninger K et al (2020) Determination of surface dose in pencil beam scanning proton therapy. Med Phys 47:2277–2288

Article  CAS  PubMed  Google Scholar